Takeda, Masayuki, Nakagawa, Kazuhiko (2019) First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?. International Journal of Molecular Sciences, 20. 146pp. doi:10.3390/ijms20010146
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer? | ||
| Journal | International Journal of Molecular Sciences | ||
| Authors | Takeda, Masayuki | Author | |
| Nakagawa, Kazuhiko | Author | ||
| Year | 2019 (January 3) | Volume | 20 |
| Publisher | MDPI AG | ||
| DOI | doi:10.3390/ijms20010146Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 10071080 | Long-form Identifier | mindat:1:5:10071080:3 |
| GUID | 0 | ||
| Full Reference | Takeda, Masayuki, Nakagawa, Kazuhiko (2019) First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?. International Journal of Molecular Sciences, 20. 146pp. doi:10.3390/ijms20010146 | ||
| Plain Text | Takeda, Masayuki, Nakagawa, Kazuhiko (2019) First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?. International Journal of Molecular Sciences, 20. 146pp. doi:10.3390/ijms20010146 | ||
| In | (n.d.) International Journal of Molecular Sciences Vol. 20. MDPI AG | ||
See Also
These are possibly similar items as determined by title/reference text matching only.
